ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
This study has been terminated.
(Futility)
Sponsor:
Neurobiological Technologies
Information provided by:
Neurobiological Technologies
ClinicalTrials.gov Identifier:
NCT00300196
First received: March 6, 2006
Last updated: January 11, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |